SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-24-000062
Filing Date
2024-05-15
Accepted
2024-05-15 16:05:20
Documents
49
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20240331.htm   iXBRL 10-Q 1016117
2 EX-31.1 lumo-2024331x10qxex311.htm EX-31.1 10022
3 EX-31.2 lumo-202431x10qxex312.htm EX-31.2 10072
4 EX-32.1 lumo-2024331x10qxex321.htm EX-32.1 7058
10 GRAPHIC nlnk-20240331_g1.jpg GRAPHIC 12762
11 GRAPHIC nlnk-20240331_g2.jpg GRAPHIC 137509
  Complete submission text file 0001126234-24-000062.txt   3955119

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20240331.xsd EX-101.SCH 22939
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20240331_cal.xml EX-101.CAL 36403
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20240331_def.xml EX-101.DEF 85283
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20240331_lab.xml EX-101.LAB 278365
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20240331_pre.xml EX-101.PRE 181248
52 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20240331_htm.xml XML 321101
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 24950333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)